Medica (XPAR:MDCA) Research & Development : €0.0 Mil (TTM As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Medica Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medica's Research & Development for the six months ended in Jun. 2013 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2013 was €0.0 Mil.

Medica Research & Development Historical Data

The historical data trend for Medica's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medica Research & Development Chart

Medica Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Research & Development

Get a 7-Day Free Trial

Medica Semi-Annual Data
	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13
Research & Development	Get a 7-Day Free Trial			-	-	-	-	-

Medica Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2013 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

Medica (XPAR:MDCA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medica Research & Development Related Terms

Thank you for viewing the detailed overview of Medica's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.